MedPath
TGA Approval

ULTOMIRIS ravulizumab rch 1100 mg in 11 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial (336710)

336710

ULTOMIRIS ravulizumab rch 1100 mg in 11 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial

Alexion Pharmaceuticals Australasia Pty Ltd

March 23, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/03673dee6a630d3b5fe10624f5268b1e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/9f7ff1e1863095aa340de0da9ff657ec.pdf

Active Ingredients

ravulizumab

© Copyright 2025. All Rights Reserved by MedPath